Patients with hidradenitis suppurativa (HS) who started on or switched to biosimilar adalimumab experienced lower treatment success and lost response more quickly, according to an Australian study ...
Dr. White is Assistant Professor of Pharmacy Practice, University of Connecticut, Storrs. He also Codirector of Arrhythmia Research, Department of Pharmacy Services at Hartford (CT) Hospital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback